MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology Portfolio News / By Karina Tin July 15, 2021
Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update Portfolio News / By Karina Tin July 13, 2021
Tenaya Therapeutics Unveils Preclinical Research Supporting Product Candidate for Rare and Prevalent Heart Disease Indications at ESC Heart Failure 2021 Portfolio News / By Karina Tin July 12, 2021
Surrozen Presents New Data Demonstrating Superior Activity of SZN-1326 in Preclinical Inflammatory Bowel Disease Models at 16th Congress of the European Crohn’s and Colitis Organisation (ECCO) Portfolio News / By Karina Tin July 9, 2021
NGM Bio Announces Initiation of Phase 1/2 Clinical Study of NGM707 for the Treatment of Advanced Solid Tumors Portfolio News / By Karina Tin July 7, 2021
NGM Amends Collaboration with Merck to Focus Primarily on Advancing Novel Medicines for Retinal and Cardiovascular and Metabolic (CVM) Diseases Portfolio News / By Karina Tin July 1, 2021
Tenaya Therapeutics Announces New Appointments to Leadership Team Portfolio News / By Karina Tin June 30, 2021
Carmot to receive royalty payments upon sales of Amgen’s FDA approved first-in-class KRAS G12C Inhibitor, LUMAKRAS™ (sotorasib); Further demonstrates the value of Carmot’s therapeutic platform Portfolio News / By Karina Tin June 29, 2021
Ribon Therapeutics Appoints Paul Brannelly as Chief Financial Officer Portfolio News / By Karina Tin June 28, 2021
ORIC Pharmaceuticals Announces FDA Clearance of IND Application for ORIC-533, a Highly Potent, Orally Bioavailable Small Molecule CD73 Inhibitor Portfolio News / By Karina Tin June 28, 2021
